Decreased activity of interleukin-2 inhibitor in plasma of patients with systemic lupus erythematosus
- 1 March 1988
- journal article
- conference paper
- Published by Springer Nature in Clinical Rheumatology
- Vol. 7 (1), 87-90
- https://doi.org/10.1007/bf02284062
Abstract
Low levels of plasma interleukin-2 inhibitory activity were found in patients with systemic lupus erythematosus (SLE) compared to normal individuals. The depression of the inhibitory activity was significant in patients with severe and moderate SLE while only a slight decrease was observed in the mild form of the disease.Keywords
This publication has 24 references indexed in Scilit:
- Regulation of interleukin-2 receptor expression and receptor releaseMolecular Immunology, 1986
- An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitroJournal of Clinical Immunology, 1986
- Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.The Journal of Immunology, 1985
- Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.Journal of Clinical Investigation, 1985
- Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1984
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1982
- Soluble inhibitory factor (SIF) in normal human serumCellular Immunology, 1982
- Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.The Journal of Experimental Medicine, 1981
- Abnormalities of delayed hypersensitivity in systemic lupus erythematosusThe American Journal of Medicine, 1973